Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Traumatic brain injury (TBI) induces complex molecular and cellular responses, often leading to vision deterioration and potential mortality. Current objective diagnostic methods are limited, necessitating the development of novel tools to assess disease severity. This review focuses on the retina, a readily approachable part of the central nervous system (CNS), as a potential indicator of TBI. We...
BACKGROUND: The impact of high body mass index (BMI) states and associated proteomic factors on brain ageing and Alzheimer's disease (AD) remains unclear.
Machine learning, particularly through advanced imaging techniques such as three-dimensional Magnetic Resonance Imaging (MRI), has significantly impro...
Early detection of Alzheimer's disease (AD) remains a formidable clinical challenge, but emerging blood-based assays show promise for identifying at-r...
Alzheimer's Disease (AD) is the most prevalent neurodegenerative disorder, characterized by progressive cognitive decline. Early and accurate diagnosi...
Alzheimer's disease (AD) is a devastating neurological disorder that affects humans and is a major contributor to dementia. It is characterized by cog...
BACKGROUND: Alzheimer's disease (AD) begins years before symptoms appear, making early detection essential. The medial temporal lobe (MTL) is one of t...
BACKGROUND: The NeuroArtP3 (NET-2018-12366666) is a multicenter study funded by the Italian Ministry of Health. The aim of the project is to identify ...
BACKGROUND & AIMS: Internet use among older adults may reduce the risk of dementia, but it remains unknown how the effects vary across individuals. Th...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that often begins decades before clinical symptoms manifest. Early detection rem...
: Motoric Cognitive Risk Syndrome (MCR), defined by the co-occurrence of subjective cognitive complaints and slow gait, is recognized as a preclinical...
Mild cognitive impairment (MCI) represents an initial phase of memory or other cognitive function decline and is viewed as an intermediary stage betwe...
BackgroundCognitive decline in Alzheimer's disease (AD) often includes speech impairments, where subtle changes may precede clinical dementia onset. A...
BackgroundAlzheimer's disease (AD), marked by progressive memory loss and cognitive decline, poses diagnostic challenges due to its multifactorial nat...
Metabolic dysfunction-associated steatohepatitis (MASH) is a complex liver disease whose pathogenesis involving endoplasmic reticulum (ER) stress and ...
Alzheimer's disease (AD) is a neurodegenerative disorder that severely impairs cognitive function across various age groups, ranging from early to la...
PURPOSE OF REVIEW: This review explores the use of brain age estimation from MRI scans as a biomarker of brain health. With disorders like Alzheimer's...
PURPOSE OF REVIEW: Cardiac amyloidosis is characterized by systolic and diastolic abnormalities due to deposition of amyloid fibril within the myocard...
Heterogeneity is a fundamental characteristic of brain diseases, distinguished by variability not only in brain atrophy but also in the complexity of ...
Alzheimer's disease (AD) and atherosclerosis (AS) are two interacting diseases mostly affecting aged adults. AD is characterized by the deposition of ...